Patents by Inventor Pinglang Wang

Pinglang Wang has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Compounds with high monoamine transporter affinity
    Publication number: 20060171881
    Abstract: Featured compounds have high monoamine transport affinity and are characterized by one of the following two general formulas set out above. The compounds bind selectively or non-selectively to monoamine transporters. The compounds are useful to treat various medical indications including attention deficit hyperactivity disorder (ADHD), Parkinson's disease, cocaine addiction, smoking cessation, weight reduction, obsessive-compulsive disorder, various forms of depression, traumatic brain injury, stroke, and narcolepsy.
    Type: Application
    Filed: December 29, 2005
    Publication date: August 3, 2006
    Applicants: Organix, Inc.
    Inventors: Peter Meltzer, Paul Blundell, Pinglang Wang, Bertha Madras
  • Compounds with high monoamine transporter affinity
    Patent number: 7026516
    Abstract: Featured compounds have high monoamine transport affinity and are characterized by one of the following two general formulas set out above. The compounds bind selectively or non-selectively to monoamine transporters. The compounds are useful to treat various medical indications including attention deficit hyperactivity disorder (ADHD), Parkinson's disease, cocaine addiction, smoking cessation, weight reduction, obsessive-compulsive disorder, various forms of depression, traumatic brain injury, stroke, and narcolepsy.
    Type: Grant
    Filed: February 24, 2003
    Date of Patent: April 11, 2006
    Assignees: President and Fellows of Harvard College, Organix, Inc.
    Inventors: Peter C. Meltzer, Paul Blundell, Pinglang Wang, Bertha K. Madras
  • Compounds with high monoamine transporter affinity
    Publication number: 20040014992
    Abstract: Featured compounds have high monoamine transport affinity and are characterized by one of the following two general formulas set out above. The compounds bind selectively or non-selectively to monoamine transporters. The compounds are useful to treat various medical indications including attention deficit hyperactivity disorder (ADHD), Parkinson's disease, cocaine addiction, smoking cessation, weight reduction, obsessive-compulsive disorder, various forms of depression, traumatic brain injury, stroke, and narcolepsy.
    Type: Application
    Filed: February 24, 2003
    Publication date: January 22, 2004
    Inventors: Peter C. Meltzer, Paul Blundell, Pinglang Wang, Bertha K. Madras
  • Compounds with high monoamine transporter affinity
    Patent number: 6525206
    Abstract: Featured compounds have high monoamine transport affinity and are characterized by one of the following two general formulas set out above. The compounds bind selectively or non-selectively to monoamine transporters. The compounds are useful to treat various medical indications including attention deficit hyperactivity disorder (ADHD), Parkinson's disease, cocaine addiction, smoking cessation, weight reduction, obsessive-compulsive disorder, various forms of depression, traumatic brain injury, stroke, and narcolepsy.
    Type: Grant
    Filed: October 17, 2000
    Date of Patent: February 25, 2003
    Assignees: President and Fellows of Harvard College, Organix, Inc.
    Inventors: Peter C. Meltzer, Paul Blundell, Pinglang Wang, Bertha K. Madras